Diversified Trust CO Arcus Biosciences, Inc. Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$14.59 - $18.48 $21,403 - $27,110	1,467 Added 12.15%	13,545 $206,000
Q1 2024 Apr 18, 2024	BUY	$14.83 - $20.18 $179,116 - $243,734	12,078 New	12,078 $228,000
Q3 2022 Oct 14, 2022	SELL	$23.23 - $30.07 $8,873 - $11,486	-382 Reduced 4.23%	8,645 $226,000
Q4 2021 Jan 13, 2022	BUY	$31.38 - $48.47 $18,796 - $29,033	599 Added 7.11%	9,027 $365,000
Q1 2021 May 10, 2021	BUY	$26.16 - $41.39 $220,476 - $348,834	8,428 New	8,428 $237,000

196

51.6M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $906M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.